magnesium sulfate has been researched along with Basal Ganglia Cerebrovascular Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gianopoulos, JG; Kuban, K; Mittendorf, R; Pryde, PG; Yousefzadeh, D | 1 |
Dammann, O; Lee, KS; Mittendorf, R | 1 |
1 review(s) available for magnesium sulfate and Basal Ganglia Cerebrovascular Disease
Article | Year |
---|---|
Brain lesions in newborns exposed to high-dose magnesium sulfate during preterm labor.
Topics: Basal Ganglia Cerebrovascular Disease; Cerebral Hemorrhage; Cerebral Palsy; Female; Humans; Infant, Newborn; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Prenatal Exposure Delayed Effects; Randomized Controlled Trials as Topic; Tocolytic Agents | 2006 |
1 trial(s) available for magnesium sulfate and Basal Ganglia Cerebrovascular Disease
Article | Year |
---|---|
Antenatal risk factors associated with the development of lenticulostriate vasculopathy (LSV) in neonates.
Topics: Adult; Basal Ganglia Cerebrovascular Disease; Cerebral Hemorrhage; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Infant, Newborn; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Prospective Studies; Risk Factors; Tocolytic Agents | 2005 |